Jolanta Węgłowska

1.5k total citations
16 papers, 437 citations indexed

About

Jolanta Węgłowska is a scholar working on Immunology, Pediatrics, Perinatology and Child Health and Dermatology. According to data from OpenAlex, Jolanta Węgłowska has authored 16 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Pediatrics, Perinatology and Child Health and 5 papers in Dermatology. Recurrent topics in Jolanta Węgłowska's work include Psoriasis: Treatment and Pathogenesis (6 papers), Pharmaceutical studies and practices (6 papers) and Biosimilars and Bioanalytical Methods (3 papers). Jolanta Węgłowska is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (6 papers), Pharmaceutical studies and practices (6 papers) and Biosimilars and Bioanalytical Methods (3 papers). Jolanta Węgłowska collaborates with scholars based in Poland, Germany and France. Jolanta Węgłowska's co-authors include Melinda Gooderham, Heike Woehling, C.E.M. Griffiths, Diamant Thaçi, Sascha Gerdes, Petr Arenberger, Külli Kingo, Grażyna Pulka, Johann Poetzl and Luke Peterson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Investigative Dermatology and Journal of the American Academy of Dermatology.

In The Last Decade

Jolanta Węgłowska

12 papers receiving 431 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jolanta Węgłowska Poland 6 336 152 122 109 77 16 437
S. Jazayeri United States 7 412 1.2× 278 1.8× 36 0.3× 30 0.3× 73 0.9× 10 443
Wendell C. Valdecantos United States 17 503 1.5× 386 2.5× 39 0.3× 23 0.2× 101 1.3× 32 618
Heike Woehling Germany 9 300 0.9× 30 0.2× 142 1.2× 140 1.3× 102 1.3× 16 377
Giovanna Malara Italy 12 231 0.7× 159 1.0× 22 0.2× 25 0.2× 60 0.8× 26 347
M. Milutinovic Switzerland 7 965 2.9× 637 4.2× 82 0.7× 46 0.4× 197 2.6× 12 1.0k
Youngdoe Kim South Korea 9 148 0.4× 24 0.2× 31 0.3× 50 0.5× 43 0.6× 23 226
Katherine Armour Australia 8 165 0.5× 99 0.7× 20 0.2× 27 0.2× 23 0.3× 12 267
S. D’Adamio Italy 14 348 1.0× 235 1.5× 14 0.1× 25 0.2× 51 0.7× 23 451
Kamyar Farahi United States 7 209 0.6× 150 1.0× 31 0.3× 24 0.2× 50 0.6× 7 300
M.M.B. Seyger Netherlands 10 289 0.9× 217 1.4× 22 0.2× 81 0.7× 18 0.2× 13 363

Countries citing papers authored by Jolanta Węgłowska

Since Specialization
Citations

This map shows the geographic impact of Jolanta Węgłowska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jolanta Węgłowska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jolanta Węgłowska more than expected).

Fields of papers citing papers by Jolanta Węgłowska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jolanta Węgłowska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jolanta Węgłowska. The network helps show where Jolanta Węgłowska may publish in the future.

Co-authorship network of co-authors of Jolanta Węgłowska

This figure shows the co-authorship network connecting the top 25 collaborators of Jolanta Węgłowska. A scholar is included among the top collaborators of Jolanta Węgłowska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jolanta Węgłowska. Jolanta Węgłowska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Węgłowska, Jolanta, et al.. (2021). Intravascular large B-cell lymphoma. SHILAP Revista de lepidopterología. 108(1). 46–51.
2.
Węgłowska, Jolanta, et al.. (2020). Hypohidrotic ectodermal dysplasia. SHILAP Revista de lepidopterología. 107(6). 557–561. 4 indexed citations
3.
Schaller, Martin, Lajos Kemény, Blanka Havlíčková, et al.. (2019). A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40-mg modified-release capsules, versus topical ivermectin 1% cream and placebo in the treatment of severe rosacea. Journal of the American Academy of Dermatology. 82(2). 336–343. 46 indexed citations
4.
Lebwohl, Mark, Andrew Blauvelt, C. Paul, et al.. (2018). Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48 weeks of a phase 3, multicenter, randomized, double-blind, etanercept- and placebo-controlled study (CIMPACT). Journal of the American Academy of Dermatology. 79(2). 266–276.e5. 101 indexed citations
5.
Węgłowska, Jolanta, et al.. (2018). Pseudo-Kaposi sarcoma. Dermatology Review. 105(4). 554–557.
6.
Piguet, Vincent, Andrew Blauvelt, Daniel Burge, et al.. (2017). Certolizumab Pegol for the Treatment of Chronic Plaque Psoriasis: DLQI and WPAI Patient-Reported Outcomes from an Ongoing Phase 3, Multicenter, Randomized, Active- and Placebo-Controlled Study (CIMPACT). SKIN The Journal of Cutaneous Medicine. 1. s3–s3. 1 indexed citations
7.
Griffiths, C.E.M., Kristian Reich, Diamant Thaçi, et al.. (2017). 002 Switching treatments of etanercept biosimilar GP2015 with originator product does not impact efficacy, safety and immunogenicity in patients with chronic plaque-type psoriasis. Journal of Investigative Dermatology. 137(10). S193–S193. 6 indexed citations
8.
Papp, Kim, H. Bachelez, Antonio Costanzo, et al.. (2017). Clinical similarity of biosimilar ABP 501 to adalimumab in the treatment of patients with moderate to severe plaque psoriasis: A randomized, double-blind, multicenter, phase III study. Journal of the American Academy of Dermatology. 76(6). 1093–1102. 105 indexed citations
9.
Thaçi, Diamant, Alice B. Gottlieb, Kristian Reich, et al.. (2017). Certolizumab Pegol for the Treatment of Chronic Plaque Psoriasis: DLQI and WPAI Patient-Reported Outcomes from Two Ongoing Phase 3, Multicenter, Randomized, Placebo-Controlled Studies (CIMPASI-1 and CIMPASI-2). SKIN The Journal of Cutaneous Medicine. 1. s4–s4. 1 indexed citations
10.
11.
Węgłowska, Jolanta, et al.. (2017). Unilateral Darier’s disease – case report. Dermatology Review. 5. 555–560.
12.
13.
Węgłowska, Jolanta, et al.. (2015). Solitary extramedullary plasmocytoma of the skin. Dermatology Review. 6. 524–527.
14.
Szepietowski, Jacek C., et al.. (2006). Enhanced Enzymatic Activity of Yeast-like Fungi Responsible for Onychomycosis in Renal Transplant Recipients. International Journal of Biomedical Science. 2(1). 30–34. 2 indexed citations
15.
Węgłowska, Jolanta, et al.. (2006). Enhanced Enzymatic Activity of Yeast-like Fungi Responsible for Onychomycosis in Renal Transplant Recipients.. PubMed. 2(1). 29–33. 2 indexed citations
16.
Szepietowski, Jacek C., Adam Reich, Danuta Nowicka, Jolanta Węgłowska, & T Szepietowski. (2005). Sun Protection in Renal Transplant Recipients: Urgent Need for Education. Dermatology. 211(2). 93–97. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Jazayeri Breakdown of academic impact, for papers by Wendell C. Valdecantos Breakdown of academic impact, for papers by Heike Woehling Breakdown of academic impact, for papers by Giovanna Malara Breakdown of academic impact, for papers by M. Milutinovic Breakdown of academic impact, for papers by Youngdoe Kim Breakdown of academic impact, for papers by Katherine Armour Breakdown of academic impact, for papers by S. D’Adamio Breakdown of academic impact, for papers by Kamyar Farahi Breakdown of academic impact, for papers by M.M.B. Seyger
Rankless by CCL
2026